Objectives
In the clinical practice different specialists approach to the women with vulvar pain, often without an integrated care pathway. Despite classifications that appear to reflect specific disciplines, it is necessary to focus on the causes playing a significant role in pain origin.
Recently, musculoskeletal factors have been recognized as contributors of the mechanism of vulvodynia. Pelvic floor dysfunction generally refers to disorder of laxity (hypotonus), or overactivity (hypertonus). Hypotonus disorders, due to hormonal factors, mechanical damage, or weakness, are generally associated with urinary and fecal incontinence, as well as pelvic floor organ prolapse, but have also been implicated in contributing to pelvic pain and dyspareunia. Current conceptualizations of pelvic floor involvement in sexual dysfunction, specifically sexual pain disorders, generally implicate pelvic floor hypertonus as the underlying pathology. Pelvic floor muscle abnormalities, most notably hypertonus, have been demonstrated to contribute to dyspareunia connected vulvodynia. The mechanism of how increased muscle tone is related to pain is not completely clear. Probably persistent hypertonus is more frequently associated with an increase in neurological tone rather than a pain response. Studies have demonstrated pelvic floor muscle hyperactivity to be a part of an overall response to heightened anxiety. Pain may also trigger pelvic floor dysenergia.
The objective of this study is to evaluate the role of the physical therapy as a first line treatment multidisciplinary in vulvodynia management. The efficacy of Physical therapy was assessed by adopting VAS score.
Methods

Between
Results
After 4 months-treatment, 9 patients reported an improvement in vulvar and sexual pain with good relief (reduction of 2-3 points VAS score). Two patients lost to follow up. Three patients referred any significantly effect and were submitted to an advanced multidisciplinary management. One of this woman was treated by physiatrist for a fibromyalgia (integration with AG omega 3-6, D vitamine, Mg + triptophane, Diazepam, Magnetotherapy total body, TENS). The other two women managed by the second multidisciplinary approach made a pharmacological therapy. All women are in follow up.
Conclusions:
Vulvodynia is a complex syndrome associated to sexual dysfunctions and worstening of quality of life. The successful treatment requires intervention addressing a broad field of possible pain contributors. According to our preliminary results, Physical Therapy may play a pivotal role in improving symptoms, as first line treatment. Further investigations and highquality studies are needed in order to introduce Physical Therapy as an integral component of the multidisciplinary approach to vulvodynia, according to a standard specific protocol.
